CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)

NCT03904719 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: CM082 plus JS001

Sponsor

AnewPharma